Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07717385 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sleep More, Stress Less: 90-Day Trial of Neuralli Mood

Study acronym: NM90
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Efforia, Inc
25 trials monitored
See all monitored trials
Anxiety
3,263 trials monitored
See 159 trials at risk
Depression
3,055 trials monitored
See 173 trials at risk
This decentralized, single-arm study evaluates the effects of 90 days of daily Neuralli Mood supplementation on perceived stress, sleep disturbance, mood, anxiety, depressive symptoms, happiness, and occupational burnout in adults experiencing stress or occasional sleep disruption. Participants serve as their own controls, completing validated self-report measures before beginning supplementation and again after the 90-day intervention, with safety and adherence check-ins during the study.
Trial Details
NCT Number NCT07717385
Lead Sponsor Efforia, Inc
Collaborators: Bened Life
Conditions
(from sponsor)		 Psychological Stress, Sleep Disturbance, Anxiety Symptoms, Depressive Symptoms, Occupational Burnout
Related terms Anxiety Disorders, Burnout, Professional, Burnout, Psychological, Depression, Parasomnias, Stress, Psychological
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov